{
    "organizations": [],
    "uuid": "89993cb0958ff0078116b9049d0db8859011734d",
    "author": "",
    "url": "https://www.reuters.com/article/brief-sorrento-therapeutics-audit-commit/brief-sorrento-therapeutics-audit-committee-concluded-cos-financial-statements-for-3-9-months-ended-sept-30-2017-should-not-be-relied-upon-idUSFWN1QH0Q8",
    "ord_in_thread": 0,
    "title": "BRIEF-Sorrento Therapeutics- Audit Committee Concluded Co's Financial Statements For 3 & 9 Months Ended Sept 30, 2017 Should Not Be Relied Upon​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Market News February 27, 2018 / 11:29 AM / in 11 minutes BRIEF-Sorrento Therapeutics- Audit Committee Concluded Co's Financial Statements For 3 & 9 Months Ended Sept 30, 2017 Should Not Be Relied Upon​ Reuters Staff 2 Min Read Feb 27 (Reuters) - Sorrento Therapeutics Inc: * SORRENTO THERAPEUTICS - ‍ON FEB 26, AUDIT COMMITTEE CONCLUDED CO‘S FINANCIAL STATEMENTS FOR 3 & 9 MONTHS ENDED SEPT 30, 2017 SHOULD NOT BE RELIED UPON​ * SORRENTO- ‍AN OTHER-THAN-TEMPORARY IMPAIRMENT IN VALUE OCCURRED IN EQUITY METHOD INVESTMENT IN IMMUNOTHERAPY NANTIBODY FOR 3 & 9 MONTHS ENDED SEPT 30 * SORRENTO THERAPEUTICS -NANTIBODY NOTIFIED CO THAT IN JULY IT ACQUIRED ASSETS FROM PARTY RELATED TO ITS 60% OWNER, FOR ABOUT $90 MILLION CASH -SEC FILING​ * SORRENTO THERAPEUTICS - ‍REASSESSED RECOVERABILITY OF CO‘S EQUITY METHOD INVESTMENT IN NANTIBODY AFTER NANTIBODY NOTIFIED CO OF JULY ACQUISITION​ * SORRENTO THERAPEUTICS INC - ‍IMPACT ON CO‘S 40% EQUITY INTEREST IN NANTIBODY IS A $36 MILLION IMPAIRMENT ON EQUITY METHOD INVESTMENT IN STATEMENT OF OPERATIONS * SORRENTO THERAPEUTICS INC - ‍ IMPAIRMENT EXPENSE RELATED TO NANTIBODY WILL NOT RESULT IN CASH EXPENDITURES IN PAST OR FUTURE PERIODS​ Source text: [ bit.ly/2GMrJy2 ] Further company coverage:",
    "published": "2018-02-27T13:26:00.000+02:00",
    "crawled": "2018-02-27T13:48:24.012+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "market",
        "news",
        "february",
        "minute",
        "audit",
        "committee",
        "concluded",
        "co",
        "financial",
        "statement",
        "month",
        "ended",
        "sept",
        "relied",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "sorrento",
        "therapeutic",
        "inc",
        "sorrento",
        "therapeutic",
        "feb",
        "audit",
        "committee",
        "concluded",
        "co",
        "financial",
        "statement",
        "month",
        "ended",
        "sept",
        "relied",
        "impairment",
        "value",
        "occurred",
        "equity",
        "method",
        "investment",
        "immunotherapy",
        "nantibody",
        "month",
        "ended",
        "sept",
        "sorrento",
        "therapeutic",
        "notified",
        "co",
        "july",
        "acquired",
        "asset",
        "party",
        "related",
        "owner",
        "million",
        "cash",
        "sorrento",
        "therapeutic",
        "recoverability",
        "co",
        "equity",
        "method",
        "investment",
        "nantibody",
        "nantibody",
        "notified",
        "co",
        "july",
        "sorrento",
        "therapeutic",
        "inc",
        "co",
        "equity",
        "interest",
        "nantibody",
        "million",
        "impairment",
        "equity",
        "method",
        "investment",
        "statement",
        "operation",
        "sorrento",
        "therapeutic",
        "inc",
        "impairment",
        "expense",
        "related",
        "nantibody",
        "result",
        "cash",
        "expenditure",
        "past",
        "future",
        "source",
        "text",
        "company",
        "coverage"
    ]
}